Genetic susceptibility to west nile virus and dengue

Public Health Genomics

Volumn 16, Issue 1-2, 2013, Pages 4-8

  Loeb, M ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Epidemiology; Genetic; Genomic analysis of complex diseases

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; SINGLE STRANDED RNA; FC RECEPTOR IIB; HLA ANTIGEN; NEUTRALIZING ANTIBODY; VITAMIN D RECEPTOR;

ARTICLE; CD8+ T LYMPHOCYTE; DENGUE; DENGUE VIRUS; DNA POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HUMAN; INSECT BITE; MOSQUITO; NONHUMAN; PRIORITY JOURNAL; RNA VIRUS; WEST NILE FLAVIVIRUS; GENETIC VARIABILITY; HEREDITY; HLA SYSTEM; INFECTIOUS COMPLICATION; MOSQUITO BITE; VIRUS REPLICATION; WEST NILE VIRUS;

ALLELES; ANIMALS; DENGUE; DENGUE VIRUS; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HLA ANTIGENS; HOMOZYGOTE; HUMANS; MICE; POLYMORPHISM, GENETIC; WEST NILE FEVER; WEST NILE VIRUS;

DENGUE VIRUS; FLAVIVIRUS; RNA VIRUSES; WEST NILE VIRUS;

EID: 84876063869     PISSN: 16624246     EISSN: 16628063     Source Type: Journal    
DOI: 10.1159/000345934     Document Type: Article

References (20)

1. Petersen LR, Hayes EB: West Nile virus in the America. Med Clin North Am 2008; 92: 1307-1322.
2. Gubler DJ: The continuing spread of West Nile virus in North America. Clin Infect Dis 2007; 45: 1039-1046.
3. Mashimo T, Lucas M, Simon-Chazottes D, Frenkiel MP, Montagutelli X, Ceccaldi PE, Deubel V, Guenet JL, Despres P: A nonsense mutation in the gene encoding 2′-5′-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory mice. Proc Natl Acad Sci USA 2002; 99: 11311-11316.
4. Yakub I, Lillibridge KM, Moran A, Gonzalez OY, Belmont J, Gibbs RA, Tweardy DJ: Single nucleotide polymorphisms in genes for 2′-5′- oligoadenylate synthetase and RNase L in patients hospitalized with West Nile virus infection. J Infect Dis 2005; 192: 1741-1748.
5. Lim JK, Lisco A, McDermott DH, Huynh L, Ward JM, Johnson B, Johnson H, Pape J, Foster GA, Krysztof D, Follmann D, Stramer SL, Margolis LB, Murphy PM: Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man. PLoS Pathog 2009; 5:e1000321.
6. Loeb M, Eskandarian S, Rupp M, Fishman N, Gasink L, Patterson J, Bramson J, Hudson TJ, Lemire M: Genetic variants and susceptibility to neurological complications following West Nile virus infection. J Infect Dis 2011; 204: 1031-1037.
7. Bigham AW, Buckingham KJ, Husain S, Emond MJ, Bofferding KM, Gildersleeve H, Rutherford A, Astakhova NM, Perelygin AA, Busch MP, Murray KO, Sejvar JJ, Green S, Kriesel J, Brinton MA, Bamshad M: Host genetic risk factors for West Nile virus infection and disease progression. PLoS One 2011; 6:e24745.
8. Glass WG, McDermott DH, Lim JK, Lekhong S, Yu SF, Frank WA, Pape J, Cheshier RC, Murphy PM: CCR5 deficiency increases risk of symptomatic West Nile virus infection. J Exp Med 2006; 203: 35-40.
9. Lim JK, Louie CY, Glaser C, Jean C, Johnson B, Johnson H, McDermott DH, Murphy PM: Genetic deficiency of chemokine receptor CCR5 is a strong risk factor for symptomatic West Nile virus infection: a meta-analysis of 4 cohorts in the US epidemic. J Infect Dis 2008; 197: 262-265.
10. Lim JK, McDermott DH, Lisco A, Foster GA, Krysztof D, Follmann D, Stramer SL, Murphy PM: CCR5 deficiency is a risk factor for early clinical manifestations of West Nile virus infection but not for viral transmission. J Infect Dis 2010; 201: 178-185.
11. Gibbons RV, Vaughn DW: Dengue: an escalating problem. BMJ 2002; 324: 1563-1566.
12. Sakuntabhai A, Turbpaiboon C, Casadémont I, Chuansumrit A, Lowhnoo T, Kajaste-Rudnitski A, Kalayanarooj SM, Tangnararatchakit K, Tangthawornchaikul N, Vasanawathana S, Chaiyaratana W, Yenchitsomanus PT, Suriyaphol P, Avirutnan P, Chokephaibulkit K, Matsuda F, Yoksan S, Jacob Y, Lathrop GM, Malasit P, Després P, Julier C: A variant in the CD209 promoter is associated with severity of dengue disease. Nat Genet 2005; 37: 507-513.
13. Loke H, Bethell D, Phuong CX, Day N, White N, Farrar J, Hill A: Susceptibility to dengue hemorrhagic fever in Vietnam: evidence of an association with variation in the vitamin D receptor and Fc gamma receptor IIa genes. Am J Trop Med Hyg 2002; 67: 102-106.
14. Fernández-Mestre MT, Gendzekhadze K, Rivas-Vetencourt P, Layrisse Z: TNF-alpha-308A allele, a possible severity risk factor of hemorrhagic manifestation in dengue fever patients. Tissue Antigens 2004; 64: 469-472.
15. Vejbaesya S, Luangtrakool P, Luangtrakool K, Kalayanarooj S, Vaughn DW, Endy TP, Mammen MP, Green S, Libraty DH, Ennis FA, Rothman AL, Stephens HA: TNF and LTA gene, allele, and extended haplotype associations with severe dengue virus infection in ethnic Thais. J Infect Dis 2009; 199: 1442-1448.
16. Chen RF, Wang L, Cheng JT, Chuang H, Chang JC, Liu JW, Lin IC, Yang KD: Combination of CTLA-4 and TGFB1 gene polymorphisms associated with dengue hemorrhagic fever and virus load in a dengue-2 outbreak. Clinical Immunol 2009; 131: 404-409.
17. Soundravally R, Hoti SL: Immunopathogenesis of dengue hemorrhagic fever and shock syndrome: role of TAP and HPA gene polymorphism. Human Immunol 2007; 68: 973-979.
18. Fink J, Gu F, Vasudevan SG: Role of T cells, cytokines and antibody in dengue fever and dengue haemorrhagic fever. Rev Med Virol 2006; 16: 263-275.
19. Stephens HA: HLA and other gene associations with dengue disease severity. Curr Top Microbiol Immunol 2010; 338: 99-114.
20. Khor CC, Chau TN, Pang J, Davila S, Long HT, Ong RT, Dunstan SJ, Wills B, Farrar J, Van Tram T, Gan TT, Binh NT, Tri le T, Lien le B, Tuan NM, Tham NT, Lanh MN, Nguyet NM, Hieu NT, Van N, Vinh Chau N, Thuy TT, Tan DE, Sakuntabhai A, Teo YY, Hibberd ML, Simmons CP: Genome-wide association study identifies susceptibility loci for dengue shock syndrome at MICB and PLCE1. Nat Genet 2011; 43: 1139-1141.